Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EP9598 / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Body temperature, Chills, Oxygen saturation, Oxygen saturation decreased, Pyrexia
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: ACETYLSALICYLIC ACID; PREDNISOLONE; OMEPRAZOLE; CALCI CHEW D3; QUETIAPINE; TRAMADOL; RIVASTIGMINE; PROLIA
Diagnostic Lab Data: Test Date: 20210303; Test Name: body temperature; Result Unstructured Data: Test Result: Fever: 38 to 40.5 degrees Celsius Centigrade; Comments: Fever: 38 to 40.5 degrees Celsius; Test Date: 20210303; Test Name: oxygen saturation; Test Result: 67 %; Comments: decreased.
CDC 'Split Type': NLPFIZER INC2021267083
Write-up: Fever: 38 to 40.5 degrees Celsius; Cold shivers; saturation decreased; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB NL-LRB-00463754. A 66-year-old male patient received the second dose of BNT162b2 (COMIRNATY; lot number: EP9598) on 02Mar2021 at single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included acetylsalicylic acid tablet 80mg taken at 80 mg, prednisolone tablet 5mg taken at 5 mg, omeprazole gastro-resistant capsule 40mg taken at 40 mg, calcium carbonate, colecalciferol (CALCI CHEW D3) chewable tablet 2.5g / 800iU taken at 1000mg approximately, quetiapine tablet modified-release tablet 50mg taken at 50 mg, tramadol capsule modified-release 100mg taken at 100 mg, rivastigmine patch 9.5mg taken at 9.5 mg daily (24hrs), denosumab (PROLIA) solution for injection 60mg/ml taken at 60mg/ml. The patient previously took the first dose of BNT162b2 (COMIRNATY) on 01Feb2021 for COVID-19 immunisation with no adverse reaction. On 03Mar2021, the patient experienced saturation decreased, cold shivers and fever: 38 to 40.5 degrees Celsius following administration of BNT162b2. Saturation drop to 67% on 03Mar2021. The patient had not previous COVID-19 infection. No diagnostic procedures were performed. Chills was treated with amoxicilin/clavulanic acid, oxygen saturation decreased was treated with oxygen and pyrexia was treated with amoxicilin/clavulanic acid. The patient died in Mar2021. The outcome of the events was fatal. It was unknown if an autopsy was performed. Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty); past drug therapy BioNTech / Pfizer vaccine (Comirnaty): yes; ADRs: no; date: 01Feb2021; saturation additional information ADR: saturation drop to 67%; COVID-19: previous COVID-19 infection: no; other: diagnostic procedures: no. No follow-up attempts possible. No further information expected.; Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty) Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): yes ADRs: No Date: 01Feb2021 Saturation Additional information ADR: Saturation drop to 67% COVID-19 Previous COVID-19 infection: No. Other diagnostic procedures: No.; Reported Cause(s) of Death: saturation decreased; cold shivers; fever: 38 to 40.5 degrees Celsius
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166